BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 4368071)

  • 1. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 2. A role for glucagon in cardiac therapy.
    Parmley WW; Sonnenblick EH
    Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
    Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
    Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of glucagon in man.
    Parmley WW; Glick G; Sonnenblick EH
    N Engl J Med; 1968 Jul; 279(1):12-7. PubMed ID: 4872564
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular effects of glucagon in man.
    Klein SW; Morch JE; Mahon WA
    Can Med Assoc J; 1968 Jun; 98(25):1161-4. PubMed ID: 5657181
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effects of vasopressin during haemorrhagic hypotension in the anesthetized dog.
    Ericsson BF
    Acta Chir Scand; 1972; 138(3):227-33. PubMed ID: 5036819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
    Ismailov ShI; Flerov EV
    Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification in dogs of the systemic and coronary hemodynamic effects of glucagon by sotalol.
    Berndt TB; Ansfield TJ; Alfonso S; Rowe GG
    Am Heart J; 1973 May; 85(5):671-8. PubMed ID: 4697635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular effects of glucagon].
    Liakishev AA; Golikov AP
    Kardiologiia; 1972 Jul; 12(7):128-36. PubMed ID: 4364203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glucagon: effects on hemodynamics and myocardial metabolism].
    Moret P; Duchosal F; Steinmann JM
    Arch Mal Coeur Vaiss; 1972 Aug; 65(8):971-9. PubMed ID: 4633640
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of camazepam (SB-5833), a new antianxious drug, on cardiac contractility and coronary hemodynamics.
    Merlo L; Noseda V; Ferrini R; Miragoli G; Marchetti G
    Arzneimittelforschung; 1974 Nov; 24(11):1759-62. PubMed ID: 4155634
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Review of the cardiovascular pharmacology of perhexiline.
    Hudak WJ; Lewis RE; Lucas RW; Kuhn WL
    Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of cardiovascular effects of glucagon by aminophylline.
    Afonso S; Hansing CE; Ansfield TJ; Berndt TB; Rowe GG
    Cardiovasc Res; 1972 May; 6(3):235-9. PubMed ID: 4338472
    [No Abstract]   [Full Text] [Related]  

  • 14. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
    Flerov EV; Ismailov ShI
    Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifyllin) on the cardiovascular system of the dog].
    Komarek J; Sakurai M
    Arzneimittelforschung; 1974 May; 24(5):781-3. PubMed ID: 4408132
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of experimental hypercitremia.
    Corbascio AN; Smith NT
    Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulatory effects of intravenously administered rolitetracycline and other tetracyclines in animal experiments.
    Schölkens B; Gerhards H; Lindner E
    Arzneimittelforschung; 1974 Mar; 24(3):312-7. PubMed ID: 4210117
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
    Nobel-Allen N; Kirsch M; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.